Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia-Reference-Cited by-同舟云学术

Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia

Published:2019-06-28 Issue:10 Volume:66 Page:e27905
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hashmi Saman K.¹^ORCID,Punia Jyotinder N.²,Marcogliese Andrea N.²,Gaikwad Amos S.²,Fisher Kevin E.¹²,Roy Angshumoy²,Rao Pulivarthi²,Lopez-Terrada Dolores H.²,Ringrose Jo²,Loh Mignon L.³,Niemeyer Charlotte M.⁴⁵⁶,Rau Rachel E.¹^ORCID

Affiliation:

1. Department of Pediatrics; Section of Hematology Oncology; Texas Children's Hospital/Baylor College of Medicine; Houston Texas

2. Department of Pathology and Immunology; Texas Children's Hospital/Baylor College of Medicine; Houston Texas

3. Department of Pediatrics; Division of Hematology Oncology; University of California San Francisco; San Francisco California

4. Division of Pediatric Hematology and Oncology; Department of Pediatrics; University of Freiburg; Freiburg Germany

5. German Cancer Consortium; Heidelberg Germany

6. German Cancer Research Center; Heidelberg Germany

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27905/fullpdf

Reference19 articles.

1. How I treat juvenile myelomonocytic leukemia;Locatelli;Blood,2015

2. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia;Lipka;Nat Commun,2017

3. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia;Loh;Hematol Am Soc Hematol Educ Program,2010

4. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy;Loh;Clin Cancer Res,2012

5. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial;Locatelli;Blood,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Unusual Presentation of Bilateral Proptosis Presents a Dilemma in the Case of Juvenile Myelomonocytic Leukemia;Indian Journal of Medical and Paediatric Oncology;2024-07-31

2. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies;Biomolecules;2022-12-28

3. Juvenile Myelomonocytic Leukemia in a Child: A Case Report of Palliative Chemotherapy and Literature Review Applied to Limited Resources Centers;Case Reports in Hematology;2022-11-16

4. Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia;Cancers;2022-03-04

5. Azacitidine as a bridge to transplantation in juvenile myelomonocytic leukemia;Pediatrics International;2022-01